Kiwa Bio-Tech Annual Meeting Report
18 Dicembre 2012 - 8:56PM
Kiwa Bio-Tech Products Group Corporation (OTCBB:KWBT) held its
annual meeting Friday in Beijing. Over 67.1% of the total number of
shares outstanding were represented in person or by proxy at the
Annual Meeting.
Mr. Wei Li, Mr. Xucheng Hu, Mr. Lianjun Luo and Prof. Qi Wang,
as the four individuals receiving the greatest number of votes,
were elected to the Board of Directors. Each of them was elected as
a director to serve for the term expiring on the date of the
Company's 2013 annual meeting and until his or her respective
successor is duly elected and qualified.
Paritz & Company, P.A. was appointed to act as the Company's
independent auditors for the fiscal year ending December 31,
2012.
The proposal to increase the number of authorized shares to
800,000,000 from 400,000,000 failed to receive a majority of votes
in favor and therefore was not approved.
The Company develops, manufactures, distributes and markets
innovative, cost-effective, and environmentally safe
bio-technological products for agricultural and natural resources
and environmental conservation. The Company's products are designed
to enhance the quality of human life by increasing the value,
quality and productivity of crops and decreasing the negative
environmental impact of chemicals and other wastes. For more
information about the Company, please review documents filed with
the SEC (www.sec.gov) or visit the Company's website,
www.kiwabiotech.com. This press release contains information that
constitutes forward-looking statements made pursuant to the safe
harbor provisions of the Private Securities Litigation Reform Act
of 1995. Any such forward-looking statements involve risk and
uncertainties that could cause actual results to differ materially
from any future results described by the forward-looking
statements. Risk factors that could contribute to such differences
include those matters more fully disclosed in the Company's reports
filed with the Securities and Exchange Commission. The
forward-looking information provided herein represents the
Company's estimates as of the date of the press release, and
subsequent events and developments may cause the Company's
estimates to change. The Company specifically disclaims any
obligation to update the forward-looking information in the future.
Therefore, this forward-looking information should not be relied
upon as representing the Company's estimates of its future
financial performance as of any date subsequent to the date of this
press release.
CONTACT: Investor Relations
Robert Schechter
Equity Communications
212-499-6809
ir4kiwa@hotmail.com
Grafico Azioni Kiwa Bio Tech Products (CE) (USOTC:KWBT)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni Kiwa Bio Tech Products (CE) (USOTC:KWBT)
Storico
Da Giu 2023 a Giu 2024
Notizie in Tempo Reale relative a Kiwa Bio Tech Products Group Corporation (CE) (OTCMarkets): 0 articoli recenti
Più Kiwa Bio-Tech Products Group Corporation Articoli Notizie